Halozyme Therapeutics (HALO) +5% premarket after announcing an $83M global licensing agreement...

|About: Halozyme Therapeutics, Inc. (HALO)|By:, SA News Editor

Halozyme Therapeutics (HALO) +5% premarket after announcing an $83M global licensing agreement with ViroPharma (VPHM) to develop subcutaneous cinryze. (PR)